Related references
Note: Only part of the references are listed.Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome
M. Mikulska et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Prospective long-term study of hepatitis B virus reactivation in patients with hematologic malignancy
Akihiro Tamori et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Efficacy and tolerability of Entecavir for hepatitis B virus infection after hematopoietic stem cell transplantation
Jun Aoki et al.
SPRINGERPLUS (2014)
Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B
Yi-Hsiang Huang et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease
Fei W. Chen et al.
LIVER INTERNATIONAL (2013)
Hepatitis B virus infection status is an independent risk factor for multiple myeloma patients after autologous hematopoietic stem cell transplantation
Juan Li et al.
TUMOR BIOLOGY (2013)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Late onset of hepatitis B virus reactivation following hematopoietic stem cell transplantation: successful treatment with combined entecavir plus tenofovir therapy
L. Milazzo et al.
TRANSPLANT INFECTIOUS DISEASE (2012)
Genome-wide analysis of DNA methylation identifies novel cancer-related genes in hepatocellular carcinoma
Masahiro Shitani et al.
TUMOR BIOLOGY (2012)
Reactivation of resolved hepatitis B virus infection after immunosuppression: Is it time to adopt pre-emptive therapy?
Panagiotis Papamichalis et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2012)
Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT
M. Vigano et al.
BONE MARROW TRANSPLANTATION (2011)
HBV disease: HBsAg carrier and occult B infection reactivation in haematological setting
Carlo Marinone et al.
DIGESTIVE AND LIVER DISEASE (2011)
Hepatitis B virus infection: pathogenesis, reactivation and management in hematopoietic stem cell transplant recipients
Samuel E. Moses et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)
Hepatitis B Virus Reactivation following Allogeneic Hematopoietic Stem Cell Transplantation
Sarah P. Hammond et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation
Raymond Liang
BLOOD (2009)
Antiviral Resistance and Hepatitis B Therapy
Marc G. Ghany et al.
HEPATOLOGY (2009)
Lamivudine prophylaxis is effective in reducing hepatitis B reactivation and reactivation-related mortality in chemotherapy patients: a meta-analysis
Lenna A. Martyak et al.
LIVER INTERNATIONAL (2008)
Lamivudine prophylaxis and treatment of hepatitis B virus-exposed recipients receiving reduced intensity conditioning hematopoietic stem cell transplants with alemtuzumab
S. E. Moses et al.
JOURNAL OF MEDICAL VIROLOGY (2006)
Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy
CK Hui et al.
GUT (2005)
Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation
A Knöll et al.
BONE MARROW TRANSPLANTATION (2004)
Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy
W Yeo et al.
BRITISH JOURNAL OF CANCER (2004)
Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy
W Yeo et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP
MS Dai et al.
ANNALS OF HEMATOLOGY (2004)
Hepatitis B virus reactivation with clinical flare in allogeneic stem cell transplants with chronic graft-versus-host disease
P Seth et al.
BONE MARROW TRANSPLANTATION (2002)
Share Paper
